Nicoletta Loggia

CIK: 0001979825

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CADL

Candel Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

CADL
Candel Therapeutics, Inc.
Sep 30, 2026
Award(A)
Stock Option (Right to Buy)
Direct
380 shares at avg. $8.68-
CADL
Candel Therapeutics, Inc.
Jun 30, 2026
Award(A)
Stock Option (Right to Buy)
Direct
381 shares at avg. $8.64-
CADL
Candel Therapeutics, Inc.
Jun 23, 2026
Award(A)
Stock Option (Right to Buy)
Direct
32K shares-
CADL
Candel Therapeutics, Inc.
Mar 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
779 shares at avg. $4.11-
CADL
Candel Therapeutics, Inc.
Jun 25, 2025
Award(A)
Direct
2.1K shares at avg. $4.67$10K
CADL
Candel Therapeutics, Inc.
Jun 17, 2025
Award(A)
Stock Option (Right to Buy)
Direct
14.2K shares-

		Type	Shares	Price		Ownership
Sep 30, 2026	CADL Candel Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	380	$8.68	-	Direct
Jun 30, 2026	CADL Candel Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	381	$8.64	-	Direct
Jun 23, 2026	CADL Candel Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	32,000	-	-	Direct
Mar 31, 2026	CADL Candel Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	779	$4.11	-	Direct
Jun 25, 2025	CADL Candel Therapeutics, Inc.	Award(A)	2,141	$4.67	$9,998	Direct
Jun 17, 2025	CADL Candel Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	14,240	-	-	Direct

1-6 of 6 transactions

About Loggia Nicoletta

Loggia Nicoletta (SEC CIK 0001979825) files insider reports with the SEC as Director of Candel Therapeutics, Inc. (CADL).

Signal8 holds 6 ownership filings by Loggia Nicoletta, all Form 4s, filed between Jun 18, 2025 and Oct 2, 2026. Those filings report 6 transactions, from Jun 17, 2025 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Loggia Nicoletta's filings is in NEEDHAM, MA.

Recent filings by Loggia Nicoletta

Sep 30, 2026: Grant or award of CADL derivative securities (Form 4, code A).
Jun 30, 2026: Grant or award of CADL derivative securities (Form 4, code A).
Jun 23, 2026: Grant or award of CADL derivative securities (Form 4, code A).
Mar 31, 2026: Grant or award of CADL derivative securities (Form 4, code A).
Jun 25, 2025: Grant or award of CADL shares (Form 4, code A).

Other insiders filing for Candel Therapeutics, Inc. (CADL)

PAPA JOSEPH C, Director
Manning Paul B, Director
Tak Paul Peter, Chief Executive Officer
Zimmermann Martine, Director
Tyagarajan Seshu, Chief Technology Officer
Sims Mark E., Chief Commercial Officer

How to read Form 4 transaction codes